focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

Share Price Information for 1Spatial Holdings (SPA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 75.50
Bid: 74.00
Ask: 77.00
Change: 4.50 (6.34%)
Spread: 3.00 (4.054%)
Open: 71.00
High: 76.50
Low: 71.00
Prev. Close: 71.00
SPA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

6 Apr 2010 15:00

RNS Number : 7615J
Avisen PLC
06 April 2010
 

Not for release, publication or distribution, in whole or in part, in, directly or indirectly, or into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction

 

6 April 2010

 

Recommended proposal for the acquisition of Xploite plc ("Xploite") by Avisen plc

("Avisen") to be implemented by means of a Scheme of Arrangement

 

RESULT OF AVISEN GENERAL MEETING

 

On 11 March 2010, the directors of Avisen and Xploite announced that they had reached agreement on the terms of a recommended Proposal under which Avisen will acquire the entire issued and to be issued share capital of Xploite, to be implemented by means of a scheme of arrangement (the "Scheme") under Part 26 of the Companies Act 2006 (the "Act").

 

Capitalised terms used in this announcement shall have the same meaning as ascribed in the announcement dated 11 March 2010 unless the context otherwise requires.

 

Avisen is pleased to announce that, at the General Meeting held earlier today, all resolutions to provide for the implementation of the Scheme were passed.

 

The number of Avisen Shares in issue at 6.00p.m on 4 April 2010 was 141,799,928.

 

Next Steps

 

Completion of the Scheme remains subject to the satisfaction or, if permitted, waiver of the remaining conditions of the Scheme set out in the Scheme Document dated 12 March 2010 (the "Scheme Document") including, inter alia, the sanction of the Scheme by the Court and the Capital Reduction. The Court Hearings to sanction the Scheme and confirm the Capital Reduction are expected to take place on 23 April 2010 and 27 April 2010 respectively. It is expected that the last day for dealings in Xploite Shares will be 22 April 2010 and that the Scheme will become effective on 27 April 2010. If the Scheme becomes effective on 27 April 2010, it is expected that the admission to trading on AIM of the Xploite Shares will be cancelled at 7.00 a.m. on 28 April 2010 or shortly thereafter.

 

The dates stated above are indicative only and will depend, among other things, on the date upon which the Court sanctions the Scheme and confirms the associated Capital Reduction and the date on which the conditions set out in the Scheme Document are satisfied or (if capable of waiver) waived. If any of the expected dates change, Xploite will, unless the Panel otherwise directs, give notice of the change by issuing an announcement through a Regulatory Information Service.

 

Terms defined in the Scheme Document have the same meaning in this announcement, save where the context otherwise requires.

 

In accordance with Rule 19.11 of the City Code, a copy of this announcement and the Scheme Document will be published Avisen's website www.avisenplc.com and Xploite's website www.xploite.co.uk.

 

 

Enquiries:

 

Avisen plc

0870 880 2978

Marcus Hanke (Chief Executive Officer)

Zeus Capital Limited (financial adviser to Avisen)

0161 831 1512

Ross Andrews

Nick Cowles

Bishopsgate Communications (PR adviser to Avisen)

020 7562 3355

Robyn Samuelson

Siobhra Murphy

Dealing Disclosure Requirements

 

Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, "interested" (directly or indirectly) in one per cent. or more of any class of "relevant securities" of Avisen or Xploite, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant transaction. This requirement will continue until the date on which the Scheme becomes Effective, (or, if implemented by way of an offer, the offer becomes, or is declared, unconditional as to acceptances, lapses) or otherwise lapses or is withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Xploite or Avisen, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Xploite or Avisen by Avisen or Xploite, or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the Business Day following the date of the relevant transaction.

 

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

 

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXQLFBBZFEBBV
Date   Source Headline
28th Jul 20207:00 amRNSAGM Statement
27th Jul 20202:11 pmRNSAnnual General Meeting Update
15th Jul 20201:31 pmRNSDirector Share Purchase
3rd Jul 20209:34 amRNSReport and Accounts and Notice of AGM
17th Jun 20207:00 amRNSDirectorate Change
12th Jun 20207:00 amRNSUS$2.6m Contract Win with the US State of Michigan
11th Jun 20207:00 amRNSFinal Results
29th May 20207:00 amRNSNotice of Results
20th May 20205:21 pmRNSHolding(s) in Company
1st Apr 20207:34 amRNSDirector/PDMR Shareholding
23rd Mar 20207:00 amRNSTrading Update
6th Mar 20207:00 amRNSProduct Innovation
13th Feb 20205:46 pmRNSHolding(s) in Company
10th Feb 20205:41 pmRNSHolding(s) in Company
8th Jan 20207:00 amRNSBusiness Update
6th Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20197:00 amRNSHolding(s) in Company
11th Nov 20197:00 amRNSDirector Share Purchase
14th Oct 20197:00 amRNSInterim Results
8th Oct 20197:00 amRNS1Spatial London Pilot Win
13th Aug 201912:16 pmRNSHolding(s) in Company
7th Aug 20197:00 amRNSHolding(s) in Company
31st Jul 201910:31 amRNSHolding(s) in Company
30th Jul 20191:00 pmRNSResult of AGM
30th Jul 20197:00 amRNSHolding(s) in Company
28th Jun 20197:00 amRNSReport and Accounts and Notice of AGM
28th Jun 20197:00 amRNSDirector Share Purchase
31st May 20197:00 amRNSTotal Voting Rights
14th May 20197:00 amRNSFinal results for the year ended 31 January 2019
13th May 20192:50 pmRNSHolding(s) in Company
10th May 201911:23 amRNSHolding(s) in Company
8th May 20197:00 amRNSPlacing, Acquisition & Agreement with Esri
15th Mar 20197:00 amRNSTransfer of FTSE sector classification to Software
7th Mar 20197:00 amRNSTrading Update
5th Mar 20192:51 pmRNSHolding(s) in Company
20th Feb 20197:00 amRNS1Spatial Awarded Significant Contract
19th Feb 20197:00 amRNSAmendment to Enables IT Disposal Agreement
18th Jan 20197:00 amRNS1Spatial Awarded Significant Contracts
12th Dec 201811:37 amRNSDirector Shareholding
29th Nov 20189:30 amRNSHolding(s) in Company
1st Nov 20186:13 pmRNSHolding(s) in Company
30th Oct 20189:33 amRNSHolding(s) in Company
23rd Oct 20187:00 amRNSInterim Results
2nd Oct 20187:00 amRNSNotice of Results
20th Sep 20183:43 pmRNSDirector Share Purchase
7th Sep 201810:41 amRNSDirector Share Purchase
7th Sep 20187:00 amRNSDirector Share Purchase
5th Sep 20187:00 amRNSNew Long-Term Incentive Plan and Grant of Options
31st Aug 20184:56 pmRNSTotal Voting Rights
24th Aug 201810:06 amRNSDirector Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.